Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WEECO Pharma is a German pharmaceutical company specializing in the medical cannabis sector. The company focuses on the import, distribution, and manufacturing of high-quality cannabis flowers and extracts for the European market. Headquartered near Berlin, WEECO Pharma operates with full EU-GMP and EU-GDP certifications, ensuring the highest standards of pharmaceutical quality. They serve as a bridge between international cultivators and local pharmacies, providing a reliable supply chain for medicinal cannabinoids. The company's portfolio includes a variety of proprietary and third-party cannabis strains tailored for specific therapeutic needs. WEECO Pharma is actively involved in the education of healthcare professionals regarding the clinical applications of cannabis-based medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WEECO Pharma.